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health-related quality of life in AHSCT patients. The Symptom
Distress Scale (SDS) was used to identify 11 treatment-related
symptoms and the associated degree of distress. Patients’ rated
each symptom on days 30 and 100 following AHSCT with 1
indicating no awareness of a change from normal to 5, the highest
degree of discomfort. Symptom perception was a rating of a symp-
tom as  2 on the SDS; symptom evaluation was a rating of the
associated symptom distress as 2 (mild), 3 (moderate), or 4 -5
(severe). Symptoms were identiﬁed as forming groups when 3 or
more symptoms existed concurrently. Data were analyzed using
descriptive statistics and Pearson’s product-moment correlations.
Results: At day 30, patients (N67) were mostly male (69%), with
ECOG performance status 0 or 1 (82%) and a mean age of 40 years
(SD 13). Patients (n57) at day 100 were mostly male (63%),
with ECOG 0 or 1 (51%) and a mean age of 38 years (SD11). At
day 30, patients reported fatigue (90%) and appetite (79%) as the
most prevalent symptoms with appetite as the most distressing
(22%). At day 100, the most prevalent symptoms were fatigue
(81%) and appearance (60%) with fatigue as the most distressing
(11%). Several groups of co-existing symptoms were identiﬁed.
The largest group (fatigue, appetite, insomnia, bowel pattern) was
identiﬁed in 30 (45%) patients at day 30 with a signiﬁcant (p0.01)
correlation (r.50) between appetite and bowel pattern. A smaller,
prevalent group (fatigue, bowel pattern, insomnia) was identiﬁed in
17 (30%) patients at day 100 with signiﬁcant (p0.05) correlations
between: insomnia and fatigue (r.50); and insomnia and bowel
patterns (r.50). Conclusion: At a time of transitioning from
hospital discharge to the home community, patients perceive mul-
tiple symptoms with appetite (day 30) and fatigue (day 100) as
severely distressing. Symptoms coexist concurrently to form sev-
eral groups and within the larger groups, few relationships exist
between symptoms.
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The care of the pediatric patient undergoing blood and marrow
transplantation is complex and intense. Patients undergoing this
type of treatment are often critically ill and many will succumb to
their treatment or disease. Patients are often hospitalized for
months and parents/caregivers are required to stay with them for
the duration of the hospitalization. The stress and burden on both
the caregiver and the nursing staff is immense. Numerous studies
have now focused on caregiver burnout and compassion fatigue of
staff caring for these children. Burnout and turnover rates of staff
are often much higher than the National average. The Duke
Pediatric Blood and Marrow Program has developed several pro-
grams to support caregivers and staff working in this environment.
The team adheres to a primary nursing model. The primary nurs-
ing team provides continuity and consistency for both the child and
family. Additional components for our support program include a
Family Support Program and a highly trained social worker staff.
The purpose of this abstract is to present the Duke Pediatric Blood
and Marrow “Fly Me To The Moon Program”. This program was
developed to supplement existing programs that support the emo-
tional and psychosocial needs of the patient and nursing staff. The
program incorporates basic principles including bereavement ac-
tivities, nursing retention strategies and caregiver support. The
goals of the program are to reduce caregiver stress and burnout and
to support nurses caring for these patients. The presentation will be
introduced with a slide show and music, speciﬁc tools and activities
used in the program will then be discussed.
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Ethical issues and questions are a consistent aspect of caring for
Blood & Marrow Transplant (BMT) patients. The complexity of
the treatment and potential side effects are ongoing challenges.
The advancement of BMT speciﬁc treatments with new and cut-
ting edge protocols that expand our patient selection criteria, while
exciting and challenging, present nursing staff with constant ethical
questions.
On our BMT unit, monthly Nursing Ethics rounds are pre-
sented. Both night shift and day shift participate in rounds that
include the Institutional Clinical Ethicist, and BMT Program Di-
rector, a registered nurse who functions also as an adjunct ethicist
throughout the institution. A discussion topic is assigned each
month. An associated article is forwarded to all staff prior to rounds
to read as background. This is an educational opportunity for the
nursing staff to increase their knowledge of ethical principles and
dilemmas as well as an opportunity to discuss their concerns about
individual patients.
Another avenue for nursing staff to address ethical issues is
through monthly long term multidisciplinary rounds that focus on
BMT patients with extended length of stays. The multidisciplinary
group consists of the Clinical Ethicist, social worker, chaplain,
physical and occupational therapy, case management and nursing.
The bedside nurse presents the individual patient to the group.
Patients for discussion are chosen by established criteria and all
aspects of their progress and care are discussed. Many issues are
raised with resolution strategies addressed with the medical team.
Frequently in this venue, ethical concerns are discussed as the
broad picture is presented.
Both of these initiatives are venues organized by nurses and
provide the opportunity to discuss ethical issues of concern in
caring for a complex patient population as well as to establish
realistic future goals.
Multiple resources are used to select patients for discussion at
long term multidisciplinary rounds. To illustrate the methodology
used, a case study will be presented indicating the patient care
problems, concerns and suggestions by the multidisciplinary group
with patient outcomes. A list of topics discussed at monthly Nurs-
ing Ethics rounds will be presented showing the educational con-
tent that is presented to nursing staff.
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Transplant nursing brings with it a host of patient issues includ-
ing but not limited to clinical, social, emotional, and ﬁnancial. As
transplant nurses it is our responsibility to provide our patients
with the best care available. One of the most impacting complica-
tions in the hematopoietic cell transplant (HCT) patient is oral
mucositis. Oral mucositis brings with it signiﬁcant effects on the
patient’s clinical course such as pain, anorexia, dysguesia, insomnia,
and infection.
Background/Purpose: Our department’s standard for oral care
in the HCT patient included a 0.4% ﬂuoride toothpaste (Gel-
KamTM) and 0.9% saline mouth rinse every 2 hours while awake.
Beginning in November of 2005 we initiated the use of a high
concentration ﬂuoride rinse (MEDOralTM) daily in addition to our
standard regimen. We noticed over a period of months a decrease
in the severity of oral mucositis. Retrospectively, we looked at
twenty-ﬁve (14 autologous and 11 allogeneic) patients to evaluate
the addition of MEDOralTM. Patients conditioning regimens var-
ied and included agents known to increase risk of mucositis. A
preliminary evaluation showed twelve of the twenty-ﬁve patients
had evidence of oral mucositis, grade I-II. Though there appears to
be a decrease in the severity/frequency of oral mucositis in these
patients, all twelve required some type of patient controlled anal-
gesia for grade III-IV esophagitis. These ﬁndings indicate that the
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